Beaird Harris Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$15K 720
2021
Q4
$15K Buy
+100
New +$13.5K 0.01% 356

Other funds holding TNDM

Beaird Harris Wealth Management's TNDM Position: Q1 2022 in Review

Beaird Harris Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 100 shares — an estimated $15K sold.

Beaird Harris Wealth Management first reported a position in TNDM in Q4 2021 and held it in 1 quarter. The position peaked at $15K in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Beaird Harris Wealth Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 100 Tandem Diabetes Care shares in Q1 2022, an estimated $15K.
  • Beaird Harris Wealth Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 1 quarter.
  • Beaird Harris Wealth Management's Tandem Diabetes Care position peaked at $15K in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Beaird Harris Wealth Management's 13F filing for Q1 2022, filed 27 May 2022.